Fidal Launches Disputes Practice; Pinsent’s Paris Arbitration Partner Jumps to Boutique Firm, Plus Other French Moves
Two French IP law boutiques merged; Hogan Lovells hired a projects and infrastructure attorney from Gibson Dunn & Crutcher, ...
Business Insider1mon
Annexon announces topline results from RWE study of ANX005 in GBS
GBS is a rapid-onset and acute neuromuscular disease with no U.S. Food and Drug Administration-approved treatments. ANX005, the most advanced targeted immunotherapy in development for GBS ...